Vaccine Experience

Mastering the Art
of Vaccine Research

Our Commitment to Solutions

AMR’s stellar performance in vaccine trials has earned the company a reputation of excellence across the industry.

In 2020, during the global Coronavirus pandemic, one AMR clinical research center – AMR Kansas City – was selected as one of the two first centers in the nation to conduct a COVID-19 Investigational Vaccine Clinical Research Study.  Since then, AMR has worked tirelessly to obtain COVID-19 studies including vaccinations, diagnosis and treatment.

AMR is a three-time recipient of the World Vaccine Congress’s Vaccine Industry Excellence (ViE) Award for “Best Clinical Trial Site or Network” (2013, 2015, 2017) and was a finalist for this prestigious award in 2016 and 2018.

Subjects Enrolled
Vaccine Studies
Average Enrollment Goal Achieved
Average Retention Rate
Vaccine Indications
Biopharma & Government Clients

Phase I Trials

  • 2,500 subjects enrolled in 60+ Phase I studies
  • 117% average enrollment goal for phase I trials
  • 90% average retention rate for phase I trials
  • 22 Phase I vaccine indications
  • 26 Phase I biopharma and government agency

Focused Recruitment

  • Private practice access for patient-flow and database mining
  • Adjacency and partnerships with leading medical facilities in each market
  • Regularly scheduled community outreach and education program
  • Customized local media campaigns

Experienced Support Staff

  • Blinded and unblinded support staff personnel
  • Dedicated patient recruiters
  • Media, PR and marketing specialists
  • Data & QA managers
  • Licensed pharmacy technicians and trained pharmacists

Industry Leading Capabilities

  • Local PBMC processing
  • Live-attenuated vaccine handling
  • Biosafety Level II cabinets
  • Biosafety Level I & II certifications
  • Sterile drug preparation environments
  • Federal Wide Assurance (FWA) numbers
  • Established local Institutional Biosafety Committees (IBC)
AMR locations nationwide are currently seeking adults ages 18 and over for multiple Healthy Volunteer clinical research studies. AMR research centers are also enrolling in multiple COVID-19 investigational studies.